-
Tiancheng Pharmaceutical Holding AG
$1.3B
-
Biotest AG
$1.3B
Biotest is a Germany-based biotechnology company that develops and commercializes plasma protein products and biotherapeutic drugs for the treatment of cancer.
GigaGen, Inc.
$80M
GigaGen is a biotechnology company that develops and commercializes single-cell technology-based antibody drugs to treat infectious diseases.
Alkahest, Inc.
$146M
Alkahest is a biopharmaceutical company that provides treatments for neurodegenerative and age-related diseases.
Aradigm Corp.
undisclosed
Aradigm researches, discovers, develops and commercializes therapies for the treatment of severe respiratory disease.